SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: MasterBlastr, Paulieme, miracleshappen, afterhoursearnings
Search This Board: 
Last Post: 5/24/2017 11:24:23 PM - Followers: 120 - Board type: Free - Posts Today: 0


 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:

Filings and disclosure with Level 2 quotes:


(949) 396-0330


Nemus Bioscience (NMUS) Presentation (47 minutes):

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016:


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -

Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy

Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)


Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model


Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.

NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 

CANNAINVESTOR Magazine Top 20 Cannabis Stocks 


NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 


NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 


NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 


Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 


NMUS Security Details

Share Structure - as of Feb 1, 2017

Authorized Shares: 236,000,000
Outstanding Shares: 
      - Restricted  13,494,621
    - Unrestricted   8,943,542

           - Float   5,005,713 a/o Mar 23, 2016 
   Par Value 0.001

Transfer Agent: Clear Trust, LLC

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 05/12/2017 04:49:26 PM
NMUS News: Quarterly Report (10-q) 05/12/2017 04:48:59 PM
NMUS News: Current Report Filing (8-k) 05/04/2017 05:20:54 PM
NMUS News: Amended Statement of Beneficial Ownership (sc 13d/a) 03/28/2017 04:24:31 PM
NMUS News: Statement of Changes in Beneficial Ownership (4) 03/28/2017 10:53:24 AM
#2002  Sticky Note $NMUS $20 Million Dollar Bankroll and a Solid The Rainmaker 05/06/17 05:55:18 PM
#1508  Sticky Note $NMUS / $GWPH BEST IN CLASS Oncology Potential Underrated Momostocktrades 03/06/17 07:59:34 PM
#2319   I'll rephrase since you want to cue on Vinpat 05/24/17 11:24:23 PM
#2318   Why don't you explain how it works then, CJ? AntonChigurh 05/24/17 11:09:17 PM
#2317   "Schneider signed a non-disclosure and got to see cjarmstrong 05/24/17 10:18:35 PM
#2316 your ignorance. cjarmstrong 05/24/17 10:04:38 PM
#2315   Of course they invested with what you call Vinpat 05/24/17 03:46:53 PM
#2314   Look at their pipeline from 2015 and look AntonChigurh 05/24/17 03:24:01 PM
#2313   I thought the analysis on this board regarding Closewatcher 05/24/17 03:10:59 PM
#2312   I don't think that is what Vinpat is AntonChigurh 05/24/17 02:59:29 PM
#2311   LOL They didn't invest with insider information!??! Who gives Closewatcher 05/24/17 02:55:52 PM
#2310   LOL They didn't invest with insider information!??! Who gives Closewatcher 05/24/17 02:55:52 PM
#2309   Schneider didn't invest with inside information. To suggest cjarmstrong 05/24/17 02:41:25 PM
#2308   cannabinoid bio tech industry comparisons chart AntonChigurh 05/24/17 12:56:23 PM
#2307   What they did sure worked... now that they The Rainmaker 05/24/17 02:12:57 AM
#2306   It was actually closer to 3 million shares. Vinpat 05/24/17 01:30:09 AM
#2305   i figured the early vcs but that is TrueTrades 05/24/17 12:22:50 AM
#2304   yes please be clear and rational TrueTrades 05/24/17 12:11:21 AM
#2303   That was from a group of traders who Vinpat 05/24/17 12:08:57 AM
#2302   But i thought markets were efficient! :P AntonChigurh 05/23/17 11:58:53 PM
#2301   Vinpat, why did the shell guys from Miami AntonChigurh 05/23/17 11:56:55 PM
#2300   I don't know why chico says 3 months AntonChigurh 05/23/17 11:51:09 PM
#2299   its a shame someone dumped out last october TrueTrades 05/23/17 09:35:06 PM
#2298   I am honestly not even upset about that. afterhoursearnings 05/23/17 08:48:35 PM
#2295   Yeah, I took a look at the posting RtRock084 05/23/17 05:53:14 PM
#2293   Yup. They might be able to pull off DarrenE 05/23/17 05:02:06 PM
#2292   Im not here to do your DD for chico hombre2 05/23/17 05:01:54 PM
#2291   Thanks for the reply, always appreciate the education DarrenE 05/23/17 04:58:37 PM
#2290   VANCOUVER, May 23, 2017 /CNW/ - InMed Pharmaceuticals, Paulieme 05/23/17 04:58:07 PM
#2289   Seriously what clinical trials were you talking about RtRock084 05/23/17 04:51:17 PM
#2288   Theee was literally no volume for the first Vinpat 05/23/17 04:50:28 PM
#2287   I've learned more from him than he has Vinpat 05/23/17 04:42:44 PM
#2286   I agree on Tetra, thanks again for the response. RtRock084 05/23/17 04:42:40 PM
#2285   I've been meaning to ask...why was this stock DarrenE 05/23/17 04:24:23 PM
#2284   What are you referring to when you say DarrenE 05/23/17 04:22:49 PM
#2282   you are no dolt yourself TrueTrades 05/23/17 04:12:08 PM
#2281   what clinical trials are you referring to? were AntonChigurh 05/23/17 04:02:37 PM
#2280   3 months, why would chico say 3 months? chico hombre2 05/23/17 03:47:47 PM
#2279   Vinpat is a smart guy. AntonChigurh 05/23/17 03:46:16 PM
#2278   Even if the FDA changed their stance which Vinpat 05/23/17 03:17:24 PM
#2277   imo nemus has paths too well planned to TrueTrades 05/23/17 02:35:41 PM
#2276   Thanks I didn't know the conversion price would RtRock084 05/23/17 02:14:33 PM
#2275   Thanks for the response, RtRock084 05/23/17 02:12:50 PM
#2274   I don't think they will attempt to uplist Vinpat 05/23/17 01:39:44 PM
#2273   Doubt it. The latest placement by Schneider's it AntonChigurh 05/23/17 01:38:51 PM
#2272   What do you think about NMUS's plan to RtRock084 05/23/17 01:09:07 PM
#2271   I think GW is the product of the Vinpat 05/23/17 02:22:45 AM
#2270   I've been going through old Mad Money episodes AntonChigurh 05/22/17 11:18:10 PM
#2269   there is 3 mod spots available TrueTrades 05/22/17 05:00:54 PM
#2268   Each board moderator gets one sticky post. You The Rainmaker 05/22/17 04:21:13 PM
#2267   Admin..sticky what i am replying to!! Good take here afterhoursearnings 05/22/17 03:48:51 PM
#2266   GW has been at it for about 20 Vinpat 05/22/17 02:50:24 PM